Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Carotid Artery Disease
Interventions
DEVICE

PROTÉGÉ™ GPS™ and PROTÉGÉ™ RX Carotid Stent Systems and SpiderFX™ Embolic Protection Device

Carotid artery stenting with distal embolic protection.

Trial Locations (2)

Unknown

Stony Brook University Hospital, Stony Brook

Wellmont Medical Center, Kingsport

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT00530504 - Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study | Biotech Hunter | Biotech Hunter